Brazil, "The land of the future, and always will be". Can't even play futbal anymore. The most popular presidnet Brazil has had in the last 50 years, was basically a communist........and he did a great job.
This10K is probably the last word, thru April 30 and no mention of the $2 million from the Chinese I guess that
"closed" afterwards but a news release and a PR has a lot of boiler plate deny ability behind it. Real SEC filing not so much. This is over, operating deficiency eats it all up anyway. The Radmax is a total bust and the
much regaled engineers and others were just part of the scam. Sit back and watch the pump and dump as they get the last pennies out from the suckers. This stock is worthless, in my opinion.
Is you look at cash as the critical point of valuation especially in a Chinese stock (or for that matter real estate ownership in China) everybody wants it and it can disappear very fast, into the mist. I value EJ on their financial performance and payout policy, which is unusual and very attractive. What I cannot see is how they parlay that into a reward that justifies the risk given the real estate environment in which they operate in China. It may be there but I cannot see even another $17 stock price in the near term, added to the long term I have already held the stock, and I thought $17 was way short of the risk/reward ratio expected.. I am out and will be back when the China real estate market and the interesting transborder agreements they have entered in to
have a clearer path forward. Just my opinion.
Okay, thanks for the reply. I have been holding this for many years and have not seen the kind of risk/reward
I expected, in the meantime the Chinese real estate market has become a can of worms so while I am perfectly willing to gamble, as an investor I want to do that with the odds in my favor. I know there has been talk about transborder affiliations that could better position EJ to participate in the foreign acquisitions by Chinese
investors, but I can't come up with a hard number that would be a game changer at this point. I really do not know what is going to happen near term, and I have held this long enough. Just my opinion., but I am going to unload and come back to this later if things settle down.
The pump and dump continues, but the returns are less and less, someone continues to unload IMHO.
Who could it possibly be, the world wonders?
my, my, touched a nerve. It can be a $6 stock this month but of course only with the reverse split gimmick, a twentieth of the current sharecount, followed by shorting back to pennies as you go belly up. You forgot to mention that, sonny.
That makes it a $4billion company in one year. You cannot be serious. By the way, what new revenue, from where, and how much do you see coming in right now?
No way to know for sure when, but the R/S will be approved and there is no apparent reason to hold it up so I expect it will be right away and in my view maxed at 20/1. That generally means that 20,000 shares at .30 cents becomes 1000 shares at $6. $6 in my view is a short's bonanza, and they will drive it right back down again but you will only own a fraction of your previous shares. We will soon know. Someone posted that their
early biotech shares did better than this. but the volatility at this stage is not unique and will likely continue beyond stage ll and lll,. The time to buy retail on that volatility in my opinion is after the stage when there is a clear path forward for success. In my view, that is not the case today. JMHO.
"Yes, I actually did notice this and am still waiting for clarification from the company." What clarification to you need? It is in the proxy, which will pass, and you will vote for it. It is in my opinion just another SOP license to steal, at the expense of the general shareholders. If authorized shares had been reduced proportionately,
you would vote differently? They rarely are. You are a self proclaimed expert in biotech star-ups, but your
naivete says otherwise. Retail shareholders are routinely washed out in just this same scenario, insiders take care of themselves. Here is another clue. They want the big money, the institutional investors, no more the retail goggle eyed hopeful, not enough money there to keep the machine running. However there are institutional investors, sector investors, and so on, and then there are activist investors, like Icahn, Ackman, et alia.
The latter are the only ones that will actually vote against the proxy recommendations, that matter. This company is not on any one their radar screens, but the shorts will jump on an authorized 20/1 R/S and they come from everywhere. Your advice is badly timed and uninformed, in my humble opinion. Have a nice evening, thinking over the shareprice reaction.
Proxy for AGM asks for authorization up to a 20 to 1 reverse split. How many have noticed the part where
they nevertheless maintain the current authorized share count?. What this means is that insiders can continue to dilute pretty much ad infinitum, if for no other reason than to keep the extravagant compensation plan running, irrespective of results for general shareholders. This is where you see the separation from the
loyal retail holders, who are also put at risk of being shorted out by this R/S. Insiders will not share your fate.This Is SOP for early biotechs, most of which fail and even the ones that carry on, do so by washing out their original retail investors. Watch and learn. JMHO.
"Comparing the fundamentals of a global insurance company like AIG to that of a young biotech company like BCLI is comparing apples to oranges" Spin, spin, spin, that is all you have. I cited AIG as an example of an R/S which worked, the point being BCLI is nothing like AIG. Try a course in reading comprehension, along with your mail order Cliff notes on investing. Here is a clue. Investing is gambling, but with the odds in your favor. Exposing yourself to being shorted out following an untimely R/S doesn't do it. You can buy in later for a little more but keep your sharecount. Listen and learn.
R/S is rarely successful, for very good and obvious reasons. It does not change the fundamentals. This company would need at least a 15/1 RS to get the price over the $5 threshold that most funds require to invest.
At a $5 price and no change in fundamentals, the shorts would have a bonanza and ride it right back down into the pennies, washing out the longs (who would have 1/15the their original sharecount at $.35). Wash, rinse, repeat. Make no mistake, the insiders will not share your fate. They simply issue themselves new subscription rights at a great price. You do not get that benefit. On the other hand, an R/S can make sense under a couple of different scenarios. For example, when a company has solid fundamentals but for some reason the stock is in disfavor. AIG is the perfect example. A London subsidiary got into credit default swaps
which had to be bailed out and much of the group sold off, but the insurance business that was left was rock solid, so they did a high ratio R/S and the price held and the company is prospering.. Another scenario has to do with timing. As other posters have noted, you only want to see a reverse split (if at all) when the company has a clear track forward to grow. Contracts, product approvals, etc. Ironically, if that is the case, you probably don't really need an R/S because the company is succeeding the old fashion way, through creativity,
hard work, and leadership. In other word, you only want to see an R/S when their is very little chance the
shorts will take it out. This company is nowhere near that point in my view, and the timing for an R/S is
wrong, at least for longs. JMHO.
Jimmy the pump and dump I am observing is the recent trading itself .....small trades to drive the price up, followed by dumping of larger trades. It is classic, but maybe it is just temporary phenomena?. Let's watch. No news at all, though there is presumably cash available for a bulletin or two.....all of which raises yet another red flag. SOP here.